Epirubicin,Cisplatin,Capecitabine,Paclitaxel,Carboplatin,Docetaxel,oxaliplatin,Leucovorin,5-Fluorouracil
Not Tagged
[]
neo-aegis randomized ct2-3 n0-3 m0 esophageal cancer patients randomized to cross vs periop chemo no os difference (55 vs 57% at 3 years)
but higher rate of r0, pcr with cross #gi23 
Radiation Oncologist at the Princess Margaret Cancer Centre. 

Assistant Professor at the University of Toronto.

Tweets are my own.